Inhibition of the HH pathway in PDAC cell-based xenograft models through Smo inhibition has been shown to reduce GLI1 activity and tumor growth (Feldmannet al., 2007;Thayeret al., 2003;Yauchet al., 2008). Here, GLI1 is linked to neoplasm.